Migraine in pregnancy and lactation: A clinical review

Journal of Family Planning and Reproductive Health Care

Volumn 33, Issue 2, 2007, Pages 83-93

  MacGregor, E Anne ^a,b  

^a City of London Migraine Clinic   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; AMITRIPTYLINE; ATENOLOL; BUCLIZINE; CHLORPROMAZINE; CODEINE; CYCLIZINE; DICLOFENAC; DIHYDROERGOTAMINE; DOMPERIDONE; DOXYLAMINE; ELETRIPTAN; ERGOTAMINE; ESTROGEN; FROVATRIPTAN; GABAPENTIN; IBUPROFEN; MAGNESIUM SULFATE; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; PARACETAMOL; PREDNISOLONE; PROCHLORPERAZINE; RIZATRIPTAN; SUMATRIPTAN; UNINDEXED DRUG; ZOLMITRIPTAN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LACTATION; MIGRAINE; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PUERPERIUM; REVIEW;

ADULT; FEMALE; GREAT BRITAIN; HUMANS; LACTATION; MIGRAINE DISORDERS; PREGNANCY;

EID: 34147166617     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118907780254312     Document Type: Review

References (72)

1. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991; 44: 1147-1157.
2. Higgins J, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 (updated September 2006). Chichester, UK: John Wiley & Sons, 2006.
3. Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 1990; 38: 325-328.
4. Ashkenazi J, Goldman JA, Dicker D, Feldberg D, Goldman GA. Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles. Fertil Steril 1990; 53: 738-740.
5. Amir BY, Yaacov B, Guy B, Gad P, Itzhak W, Gal I. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment. Headache 2005; 45: 215-219.
6. Aromaa M, Rautava P, Helenius H, Sillanpää ML. Prepregnancy headache and the well-being of mother and newborn. Headache 1996; 36: 409-415.
7. Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999; 39: 625-632.
8. Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23: 197-205.
9. Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000; 20: 701-707.
10. Melhado E, Maciel JA Jr, Guerreiro CA. Headaches during pregnancy in women with a prior history of menstrual headaches. Arq Neuropsiquiatr 2005; 63: 934-940.
11. Wright G, Patel M. Focal migraine and pregnancy. BMJ 1986; 293: 1557-1558.
12. Chancellor AM, Wroe SJ, Cull RE. Migraine occurring for the first time in pregnancy. Headache 1990; 30: 224-227.
13. Cupini LM, Matteis M, Traisi E, Calabresi P, Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995; 15: 140-144.
14. Mandel S. Hemiplegic migraine in pregnancy. Headache 1988; 28: 414-416.
15. Wainscott G, Sullivan M, Volans G, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad Med 1978; 54: 98-102.
16. Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy. Cephalalgia 1997; 17: 765-769.
17. Banhidy F, Acs N, Horvath-Puho E, Czeizel AE. Maternal severe migraine and risk of congenital limb deficiencies. Birth Defects Res A Clin Mol Teratol 2006; 76: 592-601.
18. Rotton WN, Sachtleben MR, Friedman EA. Migraine and eclampsia. Obstet Gynecol 1959; 14: 332-330.
19. Moore MP, Redman CW. Case-control study of severe pre-eclampsia of early onset. BMJ 1983; 287: 580-583.
20. Marcoux S, Berube S, Brisson J, Fabia J. History of migraine and risk of pregnancy-induced hypertension. Epidemiology 1992; 3: 53-56.
21. Facchinetti F, Allais G, D'Amico R, Benedetto C, Volpe A. The relationship between headache and preeclampsia: a case-control study. Eur J Obstet Gynecol Reprod Biol 2005; 121: 143-148.
22. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005; 64: 614-620.
23. Banhidy F, Acs N, Horvath-Puho E, Czeizel AE. Pregnancy complications and delivery outcomes in pregnant women with severe migraine. Eur J Obstet Gynecol Reprod Biol 2006 [Epub 8 November 2006].
24. Adeney KL, Williams MA, Miller RS, Frederick IO, Sorensen TK, Luthy DA. Risk of preeclampsia in relation to maternal history of migraine headaches. J Matern Fetal Neonatal Med 2005; 18: 167-172.
25. Stein G, Morton J, Marsh A, Collins W, Branch C, Desaga U, et al. Headaches after childbirth. Acta Neurol Scand 1984; 69: 74-79.
26. Scharff L, Marcus DA, Turk DC. Headache during pregnancy and in the postpartum: a prospective study. Headache 1997; 37: 203-210.
27. Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, et al. Pregnancy and the risk of stroke. N Engl J Med 1996; 335: 768-774.
28. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509-516.
29. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006; 67: 2154-2158.
30. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006; 67: 2159-2163.
31. Campbell OM, Gray RH. Characteristics and determinants of postpartum ovarian function in women in the United States. Am J Obstet Gynecol 1993; 169: 55-60.
32. Dawson-Basoa MB, Gintzler AR. 17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res 1993; 601: 241-245.
33. Hanington E. Migraine is a platelet disorder. Headache 1987; 27: 401-402.
34. Bonnar AJ, NcNicol GP, Douglas AS. Coagulation and fibrinolytic mechanisms during and after normal childbirth. BMJ 1970; 2: 200-203.
35. Redman CW, Bonnar J, Beilin LJ. Early platelet consumption in pre-eclampsia. BMJ 1978; 1: 467-469.
36. Amery WK, Vandenbergh V. What can precipitating factors teach us about the pathogenesis of migraine? Headache 1987; 27: 146-150.
37. The National Teratology Information Service. http://www.spib.axl.co.uk [Accessed 25 December 2006].
38. Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Aspirin and congenital malformation. Lancet 1976; 1: 1373-1375.
39. Steiner TJ, MacGregor EA, Davies PTG. Guidelines for All Doctors in the Diagnosis and Management of Migraine and Tension-Type Headache (2nd edn) (British Association for the Study of Headache Management Guidelines). 2004. http://64.227.208.149/NS_BASH/BASH_guidelines_1Feb06.pdf [Accessed 25 December 2006].
40. Byron M. Treatment of rheumatic diseases. In: Rubin P (ed.), Prescribing in Pregnancy (3rd edn). London, UK: BMJ Books, 2000; 87-100.
41. Czeizel AE. Teratogenicity of ergotamine. J Med Genet 1989; 26: 69-70.
42. Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 2000; 182: 159-163.
43. Shuhaiber S, Pastuszak A, Schick B, Matsui D, Spivey G, Brochu J, et al. Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998; 51: 581-583.
44. O'Quinn S, Ephross SA, Williams V, Davis RL, Gutterman DL, Fox AW. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 1999; 263: 7-12.
45. Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. Pregnancy outcome following prescription for sumatriptan. Headache 2000; 40: 20-24.
46. Kallen B, Lygner P. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001; 41: 351-356.
47. Marcus DA, Scharff L, Turk DC. Nonpharmacological management of headaches during pregnancy. Psychosom Med 1995; 57: 527-535.
48. Scharff L, Marcus DA, Turk DC. Maintenance of effects in the nonmedical treatment of headaches during pregnancy. Headache 1996; 36: 285-290.
49. Nelson-Piercy C, De Swiet M. Diagnosis and management of migraine. Low dose aspirin may be used for prophylaxis. BMJ 1996; 313: 691-692.
50. Butters L, Kennedy S, Rubin P. Atenolol in essential hypertension during pregnancy. BMJ 1990; 301: 587-589.
51. Habib A, McCarthy JS. Effects on the neonate of propranolol administered during pregnancy. J Pediatr 1977; 91: 808-811.
52. Lindhout D, Schmidt D. In utero exposure to valproate and neural tube defects. Lancet 1986; 1: 1392-1393.
53. Buckner KD, Chavez ML, Raney EC, Stoehr JD. Health food stores' recommendations for nausea and migraines during pregnancy. Ann Pharmacother 2005; 39: 274-279.
54. Marcus DM, Snodgrass WR. Do no harm: avoidance of herbal medicines during pregnancy. Obstet Gynecol 2005; 105(5 Pt 1): 1119-1122.
55. Borrelli F, Capasso R, Aviello G, Pittler MH, Izzo AA. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 2005; 105: 849-856.
56. Emelianova S, Mazzotto P, Einarson A, Koren G. Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clin Invest Med 1999; 22: 106-110.
57. Ahluwalia IB, Morrow B, Hsia J. Why do women stop breastfeeding? Findings from the Pregnancy Risk Assessment and Monitoring System. Pediatrics 2005; 116: 1408-1412.
58. Wojnar-Horton RE, Hackett LP, Yapp P, Dusci LJ, Paech M, Ilett KF. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol 1996; 41: 217-221.
59. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000; 20: 107-113.
60. Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 2001; 41: 171-177.
61. Rozen TD. Aborting a prolonged migrainous aura with intravenous prochlorperazine and magnesium sulfate. Headache 2003; 43: 901-903.
62. Lance J, Anthony M. Some clinical aspects of migraine. Arch Neurol 1966; 15: 356-361.
63. Somerville BW. A study of migraine in pregnancy. Neurology 1972; 22: 824-828.
64. Manzoni GC, Farina S, Granella F, Alfieri M, Bisi M. Classic and common migraine suggestive clinical evidence of two separate entities. Funct Neurol 1986; 1: 112-122.
65. Ratinahirana H, Darbois Y, Bousser M-G. Migraine and pregnancy: a prospective study in 703 women after delivery. Neurology 1990; 40(Suppl. 1): 437.
66. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12: 221-228.
67. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993; 33: 385-389.
68. Chen T-C, Leviton A. Headache recurrence in pregnant women with migraine. Headache 1994; 34: 107-110.
69. MacGregor EA, Igarashi H, Wilkinson M. Headaches and hormones: subjective versus objective assessment. Headache Quarterly 1997; 8: 126-136.
70. Kelman L. Women's issues of migraine in tertiary care. Headache 2004; 44: 2-7.
71. Ertresvag JM, Zwart JA, Heide G, Johnsen HJ, Bovim G. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 2005; 111: 233-237.
72. http://www.perinatology.com/exposures/druglist.htm [Accessed 30 December 2006].